Clinitech Laboratory LimitedBSE: CTLLAB

Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015

· Issued by Clinitech Laboratory Limited via BSE India

Filed with BSE · · 3 pages · English

Summary by 6ix AI

Clinitech Laboratory Limited submitted a statement of deviation or variation regarding the utilization of funds raised through a public issue, as required by regulations. The report confirms that there has been no deviation or variation in the use of the funds as of the end of September. All funds raised have been fully utilized for the disclosed purposes, including expansion and corporate expenses.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Clinitech Laboratory Limited on 6ix

Story so far

Earlier from Clinitech Laboratory

Later from Clinitech Laboratory

All Clinitech Laboratory news releases